Literature DB >> 23808804

Synthesis and characterization of a proton transfer salt between 2,6-pyridinedicarboxylic acid and 2-aminobenzothiazole, and its complexes and their inhibition studies on carbonic anhydrase isoenzymes.

Halil İlkimen1, Cengiz Yenikaya, Musa Sarı, Metin Bülbül, Ekrem Tunca, Hakan Dal.   

Abstract

A novel proton transfer compound (HABT)(+)(Hdipic)(-) (1) obtained from ABT and H2dipic and its metal complexes (2-5) have been prepared and characterized by spectroscopic techniques. Single crystal X-ray diffraction method has also been applied to 2 and 5. While complex 2 has a distorted octahedral conformation, 5 exhibits a distorted square pyramidal structure. The structures of 3 and 4 might be proposed as octahedral according to experimental data. All compounds were also evaluated for their in vitro inhibition effects on hCA I and II for their hydratase and esterase activities. Although there is no inhibition for hydratase activities, all compounds have inhibited the esterase activities of hCA I and II. The comparison of the inhibition studies of 1-5 to parent compounds indicates that 1-5 have superior inhibitory effects. The inhibition effects of 2-5 are also compared to inhibitory properties of the metal complexes of ABT and H2dipic, revealing an improved transfection profile.

Entities:  

Keywords:  2-Aminobenzothiazole; carbonic anydrase; dipicolinic acid; inhibition; proton transfer

Mesh:

Substances:

Year:  2013        PMID: 23808804     DOI: 10.3109/14756366.2013.782299

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  1 in total

1.  A novel proton transfer salt of 2-amino-6-sulfamoylbenzothiazole and its metal complexes: the evaluation of their inhibition effects on human cytosolic carbonic anhydrases.

Authors:  Zeynep Alkan Alkaya; Halil İlkimen; Cengiz Yenikaya; Yasemin Kaygısız; Metin Bülbül; Tuncay Tunç; Musa Sarı
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.